AbbVie Gross Profit from 2010 to 2024

ABBV Stock  USD 180.35  1.16  0.65%   
AbbVie Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about 25.2 B in 2024. Gross Profit is the profit AbbVie Inc makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
2010-12-31
Previous Quarter
7.4 B
Current Value
11.9 B
Quarterly Volatility
2.6 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 B, Interest Expense of 1.1 B or Selling General Administrative of 8 B, as well as many exotic indicators such as Short Term Coverage Ratios of 5.75, Price Earnings Ratio of 59.09 or Price To Sales Ratio of 3.39. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
This module can also supplement AbbVie's financial leverage analysis and stock options assessment as well as various AbbVie Technical models . Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of AbbVie Inc over the last few years. Gross profit is a required income statement account that reflects total revenue of AbbVie Inc minus its cost of goods sold. It is profit before AbbVie operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. AbbVie's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 41.53 B10 Years Trend
Slightly volatile
   Gross Profit   
       Timeline  

AbbVie Gross Profit Regression Statistics

Arithmetic Mean23,820,879,380
Geometric Mean21,667,584,211
Coefficient Of Variation45.57
Mean Deviation8,619,956,138
Median21,176,000,000
Standard Deviation10,854,015,441
Sample Variance117809651.2T
Range35.4B
R-Value0.88
Mean Square Error28486490T
R-Squared0.78
Significance0.000015
Slope2,137,263,560
Total Sum of Squares1649335116.6T

AbbVie Gross Profit History

202425.2 B
202345.5 B
202240.6 B
202138.8 B
202030.4 B
201925.8 B
201825 B

Other Fundumenentals of AbbVie Inc

AbbVie Gross Profit component correlations

0.760.350.90.960.810.840.930.99-0.40.660.360.990.660.970.950.940.78-0.56-0.960.090.950.860.450.02-0.10.630.88-0.32-0.20.33
0.760.310.940.670.970.960.830.78-0.40.580.360.740.510.710.80.660.6-0.45-0.82-0.360.760.750.28-0.060.050.520.74-0.46-0.760.75
0.350.310.260.290.260.420.460.4-0.260.610.980.19-0.240.480.470.070.220.26-0.32-0.210.150.040.1-0.280.760.360.54-0.6-0.080.13
0.90.940.260.840.960.930.860.9-0.40.660.280.890.620.850.860.840.71-0.58-0.95-0.080.880.870.450.12-0.130.570.8-0.38-0.580.57
0.960.670.290.840.740.770.840.96-0.280.570.310.950.520.980.890.930.79-0.57-0.960.120.90.820.540.13-0.130.640.85-0.41-0.120.2
0.810.970.260.960.740.930.850.83-0.430.580.30.80.540.760.810.730.65-0.59-0.87-0.240.790.830.430.02-0.030.510.73-0.46-0.690.68
0.840.960.420.930.770.930.880.85-0.460.590.480.810.510.820.880.740.66-0.44-0.88-0.350.840.760.29-0.160.160.570.88-0.48-0.630.62
0.930.830.460.860.840.850.880.95-0.390.660.480.890.560.90.970.780.7-0.47-0.87-0.070.830.790.28-0.130.090.610.83-0.46-0.290.48
0.990.780.40.90.960.830.850.95-0.380.680.420.970.570.980.970.890.77-0.53-0.960.050.910.860.470.04-0.060.630.86-0.43-0.220.38
-0.4-0.4-0.26-0.4-0.28-0.43-0.46-0.39-0.38-0.29-0.29-0.37-0.36-0.35-0.43-0.33-0.420.440.390.18-0.46-0.44-0.020.34-0.02-0.33-0.450.030.24-0.24
0.660.580.610.660.570.580.590.660.68-0.290.570.590.290.680.690.460.59-0.21-0.620.10.530.550.270.260.170.560.58-0.41-0.240.39
0.360.360.980.280.310.30.480.480.42-0.290.570.21-0.220.490.520.080.260.26-0.33-0.370.20.070.08-0.360.80.40.57-0.63-0.140.24
0.990.740.190.890.950.80.810.890.97-0.370.590.210.730.930.920.970.78-0.63-0.950.130.960.890.450.06-0.240.60.83-0.23-0.190.33
0.660.51-0.240.620.520.540.510.560.57-0.360.29-0.220.730.470.540.770.45-0.55-0.560.210.770.650.14-0.11-0.480.30.520.41-0.190.3
0.970.710.480.850.980.760.820.90.98-0.350.680.490.930.470.940.880.78-0.49-0.950.070.880.790.50.050.030.660.89-0.48-0.140.25
0.950.80.470.860.890.810.880.970.97-0.430.690.520.920.540.940.820.77-0.44-0.9-0.140.880.80.31-0.120.10.680.88-0.47-0.260.48
0.940.660.070.840.930.730.740.780.89-0.330.460.080.970.770.880.820.7-0.64-0.910.20.960.830.490.06-0.330.510.81-0.08-0.150.21
0.780.60.220.710.790.650.660.70.77-0.420.590.260.780.450.780.770.7-0.48-0.79-0.030.750.730.20.07-0.070.910.72-0.42-0.180.25
-0.56-0.450.26-0.58-0.57-0.59-0.44-0.47-0.530.44-0.210.26-0.63-0.55-0.49-0.44-0.64-0.480.57-0.18-0.6-0.76-0.51-0.310.41-0.19-0.340.070.19-0.19
-0.96-0.82-0.32-0.95-0.96-0.87-0.88-0.87-0.960.39-0.62-0.33-0.95-0.56-0.95-0.9-0.91-0.790.57-0.01-0.92-0.85-0.5-0.090.12-0.64-0.880.420.36-0.35
0.09-0.36-0.21-0.080.12-0.24-0.35-0.070.050.180.1-0.370.130.210.07-0.140.2-0.03-0.18-0.010.010.090.220.51-0.57-0.17-0.160.420.62-0.63
0.950.760.150.880.90.790.840.830.91-0.460.530.20.960.770.880.880.960.75-0.6-0.920.010.880.42-0.04-0.230.550.85-0.13-0.280.38
0.860.750.040.870.820.830.760.790.86-0.440.550.070.890.650.790.80.830.73-0.76-0.850.090.880.530.21-0.340.430.63-0.24-0.320.45
0.450.280.10.450.540.430.290.280.47-0.020.270.080.450.140.50.310.490.2-0.51-0.50.220.420.530.44-0.19-0.070.28-0.21-0.120.1
0.02-0.06-0.280.120.130.02-0.16-0.130.040.340.26-0.360.06-0.110.05-0.120.060.07-0.31-0.090.51-0.040.210.44-0.48-0.09-0.29-0.090.05-0.08
-0.10.050.76-0.13-0.13-0.030.160.09-0.06-0.020.170.8-0.24-0.480.030.1-0.33-0.070.410.12-0.57-0.23-0.34-0.19-0.480.160.23-0.53-0.120.12
0.630.520.360.570.640.510.570.610.63-0.330.560.40.60.30.660.680.510.91-0.19-0.64-0.170.550.43-0.07-0.090.160.69-0.48-0.170.23
0.880.740.540.80.850.730.880.830.86-0.450.580.570.830.520.890.880.810.72-0.34-0.88-0.160.850.630.28-0.290.230.69-0.37-0.30.27
-0.32-0.46-0.6-0.38-0.41-0.46-0.48-0.46-0.430.03-0.41-0.63-0.230.41-0.48-0.47-0.08-0.420.070.420.42-0.13-0.24-0.21-0.09-0.53-0.48-0.370.31-0.32
-0.2-0.76-0.08-0.58-0.12-0.69-0.63-0.29-0.220.24-0.24-0.14-0.19-0.19-0.14-0.26-0.15-0.180.190.360.62-0.28-0.32-0.120.05-0.12-0.17-0.30.31-0.8
0.330.750.130.570.20.680.620.480.38-0.240.390.240.330.30.250.480.210.25-0.19-0.35-0.630.380.450.1-0.080.120.230.27-0.32-0.8
Click cells to compare fundamentals

About AbbVie Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include AbbVie income statement, its balance sheet, and the statement of cash flows. AbbVie investors use historical funamental indicators, such as AbbVie's Gross Profit, to determine how well the company is positioned to perform in the future. Although AbbVie investors may use each financial statement separately, they are all related. The changes in AbbVie's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AbbVie's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AbbVie Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Gross Profit45.5 B25.2 B
Gross Profit Margin 0.84  0.60 

AbbVie Investors Sentiment

The influence of AbbVie's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in AbbVie. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to AbbVie's public news can be used to forecast risks associated with an investment in AbbVie. The trend in average sentiment can be used to explain how an investor holding AbbVie can time the market purely based on public headlines and social activities around AbbVie Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AbbVie's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AbbVie's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average AbbVie's news discussions. The higher the estimated score, the more favorable is the investor's outlook on AbbVie.

AbbVie Implied Volatility

    
  23.37  
AbbVie's implied volatility exposes the market's sentiment of AbbVie Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if AbbVie's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that AbbVie stock will not fluctuate a lot when AbbVie's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AbbVie in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AbbVie's short interest history, or implied volatility extrapolated from AbbVie options trading.

Pair Trading with AbbVie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbbVie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will appreciate offsetting losses from the drop in the long position's value.

Moving together with AbbVie Stock

  0.89EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against AbbVie Stock

  0.9MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.9VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.82KA Kineta Inc Report 29th of March 2024 PairCorr
  0.81CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.8DBVT DBV Technologies Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to AbbVie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbbVie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbbVie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbbVie Inc to buy it.
The correlation of AbbVie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbbVie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbbVie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbbVie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out the analysis of AbbVie Correlation against competitors.
Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is AbbVie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.67)
Dividend Share
5.99
Earnings Share
2.72
Revenue Per Share
30.723
Quarterly Revenue Growth
(0.05)
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.